Downregulation of ss18-ssx1 expression by small interfering rna inhibits growth and induces apoptosis in human synovial sarcoma cell line HS-SY-II in vitro

European Journal of Cancer Prevention

Volumn 17, Issue 5, 2008, Pages 392-398

  Peng, Changliang ^a   Guo, Wei ^a   Yang, Yi ^a   Zhao, Hui ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Small interfering RNA; SS18 SSX1; Synovial sarcomas

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CASPASE 3; CYCLIN A; CYCLIN D1; PROTEIN BCL 2; SMALL INTERFERING RNA; ONCOPROTEIN; SYT SSX FUSION PROTEIN; SYT-SSX FUSION PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FUSION GENE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSFECTION; GROWTH REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; SS18 SSX1 GENE; SYNOVIAL SARCOMA; TUMOR GROWTH; CONNECTIVE TISSUE TUMOR; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTO ONCOGENE; TUMOR CELL LINE;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN A; DOWN-REGULATION; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-1; GENES, BCL-2; HUMANS; ONCOGENE PROTEINS, FUSION; RNA, SMALL INTERFERING; SARCOMA, SYNOVIAL;

EID: 56149108580     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328305a11b     Document Type: Article

References (25)

1. Agami R (2002). RNAi and related mechanisms and their potential use for therapy. Curr Opin Chem Biol 6:829-834.
2. Boyle JP, Wu XJ, Shoemaker CB, Yoshino TP (2003). Using RNA interference to manipulate endogenous gene expression in Schistosoma mansoni spor-ocysts. Mol Biochem Parasitol 128:205-215.
3. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM (1994). Identification of novel genes, SYT and SSX, involved in the t(X; 18) (p11.2; q11.2) translocation found in human synovial sarcoma. Nat Genet 7: 502-508.
4. Deshmukh R, Mankin HJ, Singer S (2004). Synovial sarcoma: the importance of size and location for survival. Clin Orthop Relat Res 419:155-161.
5. Donzé O, Picard D (2002). RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res 30:e46.
6. Dos Santos NR, De Bruijn DR, Van Kessel AG (2001). Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer 30:1-14.
7. Enzinger FM, Weiss SW (1995). Synovial sarcoma. In: Enzinger FM, Weiss SW, editors. Soft tissue tumors. 3rd ed. St. Louis: Mosby. pp. 757-786.
8. Fligman I, Lonardo F, Jhanwar SC, Gerald WL, Woodruff J, Ladanyi M (1995). Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am J Pathol 147:1592-1599.
9. Ito T, Ouchida M, Morimoto Y, Yoshida A, Jitsumori Y, Ozaki T, et al. (2005). Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo. Cancer Lett 224:311-319. Epub 2004 December 8.
10. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M. (1998). SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 338:153-160.
11. Ladanyi M (2001). Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene 20:5755-5762.
12. Lewis JJ, Antonescu CR, Leung DH, Blumberg D, Healey JH, Woodruff JM, Brennan MF (2000). Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 10:2087-2094.
13. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods 25:402-408.
14. Ly JQ, LaGatta LM, Beall DP, Packard J (2005). Massive recurrent synovial sarcoma of the hip: radiologic-histologic correlation in a case of failed magnet therapy. Clin Imaging 29:291-293.
15. Miyagishi M, Taira K (2002). U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20:497-500.
16. Nagy P, Arndt-Jovin DJ, Jovin TM (2003). Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells. Exp Cell Res 285:39-49.
17. Novina CD, Sharp PA (2004). The RNAi revolution. Nature 430:161-164.
18. Sandberg AA, Bridge JA (2002). Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: synovial sarcoma. Cancer Genet Cytogenet 133:1-23.
19. Skytting B, Nilsson G, Brodin B, Xie Y, Lundeberg J, Uhlén M (1999). A novel fusion gene, SYT-SSX4, in synovial sarcoma. J Natl Cancer Inst 91: 974-975.
20. Sun B, Sun Y, Wang J, Zhao X, Wang X, Hao X (2006). Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma. Eur J Cancer Prev 15:258-265.
21. Uprichard SL (2005). The therapeutic potential of RNA interference. FEBS Lett 579:5996-6007. Epub 2005 Aug 15.
22. Xie Y, Skytting B, Nilsson G, Gasbarri A, Haslam K, Bartolazzi A, et al. (2002a). SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X; 18) (p11.2; q11.2) translocation. Cancer Res 62:3861-3867.
23. Xie Y, Skytting B, Nilsson G, Grimer RJ, Mangham CD, Fisher C, et al. (2002b). The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X; 18) (p11.2; q11.2) and the cell cycle machinery. Oncogene 21:5791-5796.
24. Xie Y, Tö rnkvist M, Aalto Y, Nilsson G, Girnita L, Nagy B, et al. (2003). Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene. Oncogene 22:7628-7631.
25. Zamore PD (2001). RNA interference: listening to the sound of silence. Nat Struct Biol 8:746-750.